New blood test detects breast cancer in its early stages, provides 99% accurate results

New Blood Test Detects Early-Stage Breast Cancer, Gives 99% Accurate Results | Freepik

Datar Cancer Genetics (DCG) has devised a blood test that is highly accurate in detecting early-stage breast cancer in asymptomatic individuals. In addition, the results of this test will be available within 12 days, after which patients can start early treatment.

According to the doctors, this will help many women who cannot detect it at an early stage and end up being treated only in the latter stages. The test – EasyCHeckBreast – uses a 5ml blood sample and costs Rs 6,000.

It is recommended in consultation with a qualified physician for asymptomatic women over 40 years of age. dr. Ashwini Ghaisas, director of applications at DCG, said the main goal is to reach women living with breast cancer and only find out about it when it has reached stage IV and the survival rate is only 30 percent.

“If the test result is positive, you have to go through mammography and MRI. Most often, breast cancer is discovered in the advanced stage of cancer. This test will help detect asymptomatic patients early. With the timely diagnosis, it will help to start treatment at an earlier stage and the success rate will also increase,” she said.

In clinical trials, EasyCheck-Breast was tested on 8,112 asymptomatic women with baseline cancer risk and BIRADS-1 on mammography, along with 217 known cases of breast cancer. The test had a sensitivity of 88.2 percent, with a specificity and accuracy of 99 percent.

The test was developed by DCG, which is collaborating with the Apollo Cancer Center. It uses a proprietary technology developed by the company to detect circulating tumor cells and clusters specific to breast cancer with very high accuracy.

Rajan Datar, founder and president of DCG, said: “Unfortunately, most cancers are detected at high levels, requiring more intensive and expensive treatment, with debilitating side effects and a greater risk of failure. The EasyCheck-Breast collaboration is the result years of international research and innovation and has been developed, tested and validated on population groups.”

Datar added that a simple blood sample promises early detection of cancer, even in asymptomatic individuals, and increases the chances of successful treatment and survival.

Regional CEO (Western Region) of Apollo Hospitals, Santosh Marathe said: “The test provides reassurance that a person is cancer-free and can go about their daily life without worry. Our experienced oncologists continue to assist our patients and their families by providing accurate care with comprehensive treatment modalities.

Breast cancer is the most common cancer in women worldwide. It has also surpassed lung cancer as the leading cause of cancer incidence in the world by 2020, with an estimated 2.3 million new cases, accounting for 11.7 percent of all cancers.

Epidemiological studies have shown that by 2030 there will be 2 million breast cancers worldwide. In India, the incidence of breast cancer increased by almost 50 percent between 1965 and 1985.

The estimated number of cases in India was 1.18,000 in 2016. According to the data, breast cancer in India was responsible for 13.5 percent (1,78,361) of all cancer cases and 10.6 percent (90,408) of all deaths in India. 2020.

Leave a Comment

Your email address will not be published.